As of September 2024, Orient EuroPharma has a market cap of $132.62M. This makes Orient EuroPharma the world's 19737th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $105.88M | 0.26% |
2023 | $105.61M | 7.46% |
2022 | $98.28M | -0.41% |
2021 | $98.68M | -24.43% |
2020 | $130.58M | -13.49% |
2019 | $150.94M | 6.72% |
2018 | $141.44M | -34.13% |
2017 | $214.74M | 27.58% |
2016 | $168.32M | 3.68% |
2015 | $162.35M | -14.57% |
2014 | $190.04M | -19.72% |
2013 | $236.73M | 80.35% |
2012 | $131.26M | 48.09% |
2011 | $88.64M | -41.06% |
2010 | $150.40M | 3.65% |
2009 | $145.10M | 46.91% |
2008 | $98.77M | 49.34% |
2007 | $66.14M | - |